Oncology

Latest News

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

New Developments Warrant Rethinking HCC Transplant Criteria

By Jared Kaltwasser

April 29th 2025

Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.

Women with fatigue | Image credit: Adobe Stock

Fatigue, Depression Hit Harder on Women Cancer Survivors, Data Show

By Mary Caffrey

April 29th 2025

senior scientist | Image credit: Ohio State University

Proving the Concept: A Sampler of Early-Stage Science at AACR 2025

By Mary Caffrey

April 28th 2025

NSCLC | Image: Lung Cancer Foundation of America

Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

By Mary Caffrey
Brooke McCormick

April 28th 2025

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

By AJMC Contributor

April 23rd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

February 27th 2017

Proposed Colorectal Cancer Screening Initiatives Vary in Cost-Effectiveness

Christina Mattina

A recent cost-effectiveness analysis of 4 colorectal cancer screening initiatives found that some strategies may be more valuable than others in reducing screening disparities.

February 26th 2017

Jonathan Hirsch: Precision Medicine Is the Future of Value-Based Cancer Care

Precision medicine has demonstrated clinical utility and cost-effectiveness, which is why many believe this approach will be key to value-based cancer care in the future, said Jonathan Hirsch, founder and president of Syapse.

February 24th 2017

Personalizing Cancer Treatment Based on Muscle Mass to Reduce Toxicity

Surabhi Dangi-Garimella, PhD

Using body composition metrics to guide the dose in patients receiving anthracyclines-taxane—based chemotherapy for breast cancer can reduce treatment-related toxicity.

February 23rd 2017

Podcast: Takeaways From the 5th Annual Patient-Centered Oncology Care Meeting

Presenters and panelists at the 5th annual Patient-Centered Oncology Care meeting provide their key takeaways.

February 23rd 2017

Lenalidomide Approved as Maintenance for Multiple Myeloma Following Transplant

AJMC Staff

The FDA has approved lenalidomide as maintenance therapy in patients with multiple myeloma following autologous stem cell transplant.

February 23rd 2017

Dr Joseph Alvarnas Discusses Awareness of Cancer Patients' Financial Concerns

Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology, admits that he was once “oblivious” to his patients’ concerns about the cost of cancer treatment. However, it is important for clinicians to empathize with these fears and understand how they can factor into a patient’s care choices.

February 23rd 2017

AJMC®'s Evidence-Based Oncologyâ„¢ Publishes Third Annual Immuno-Oncology Issue

The advance of CAR-T technology and the rise of immuno-oncology alongside emerging new payment models highlight the annual review in Evidence-Based Oncologyâ„¢, which looks at how researchers are harnessing the immune system to bring unprecedented results in cancer care.

February 22nd 2017

Bundled Payments and Other Cost-Management Approaches to Oncology Care

Christina Mattina

At the 5th annual Patient-Centered Oncology CareÂ® meeting, stakeholders shared their views on how bundled payments, clinical pathways, and other value-based approaches can be implemented in cancer care while ensuring adequate care quality.

February 22nd 2017

Panel Presents Unique Cost-Sharing Viewpoints in Oncology Care

Christina Mattina

Panelists from diverse vantage points in the cancer care landscape discussed the effects of cost sharing on patients in a discussion at the 5th annual Patient-Centered Oncology CareÂ® meeting.

February 22nd 2017

Integrating Patient-Centered Outcomes in APMs

Surabhi Dangi-Garimella, PhD

As payment models shift to emphasize patient experience and quality of care, a panel discussion at the 5th annual Patient-Centered Oncology CareÂ® meeting debated whether these efforts had meaningfully improved outcomes for patients.

February 22nd 2017

CVS Decision to Stop Tobacco Sales Reduced Cigarette Purchase

Surabhi Dangi-Garimella, PhD

The company's study has found a 38% drop in cigarette purchase among shoppers who visit CVS stores.

February 22nd 2017

Exercise Most Powerful Lifestyle Factor in Improving Breast Cancer Outcomes

Christina Mattina

A recent literature review, examining evidence on lifestyle changes that can reduce the risk of recurrence or death for women diagnosed with breast cancer, found that exercise can reduce the risk of both outcomes.

February 22nd 2017

Samantha Watson Describes How Cancer Patients Balance Health With Finances

As founder and CEO of The Samfund, Samantha Watson has found that most cancer patients prioritize their physical health over their financial stability, leaving them lagging behind their peers economically or even facing bankruptcy.

February 21st 2017

Age, Plan Deductible Influence Prescription Changes Among Cancer Survivors

AJMC Staff

Researchers at the American Cancer Society have found that nonelderly cancer survivors enrolled in high-deductible health plans are more likely to seek a change to a lower-cost prescription medication compared with those without a cancer history.

February 21st 2017

Specialty Pharmacies Transforming Cancer Care

Surabhi Dangi-Garimella, PhD

Specialty pharmacies can collaborate with clinical teams to harness the power of health information technology and improve cancer care, according to panelists at the 5th annual Patient-Centered Oncology CareÂ® meeting.

February 21st 2017

Cholesterol-Lowering Medications Complement Endocrine Therapy in Breast Cancer

Surabhi Dangi-Garimella, PhD

Including anti-cholesterol agents during adjuvant endocrine treatment can prevent breast cancer recurrence in hormone receptor—positive early-stage breast cancer.

February 20th 2017

TAPUR Trial Expands Who Can Join Clinical Trials, If Payers Fund Genomic Tests

Mary Caffrey

Pam Mangat, MS, associate director for the TAPUR study in the research and analysis division of the American Society of Clinical Oncology, offered an update on the study at the 5th annual Patient-Centered Oncology CareÂ® meeting.

February 20th 2017

Developments in Immunotherapy at PCOC®: The Living Drugs

Surabhi Dangi-Garimella, PhD

David L. Porter, MD, kicked off the 5th annual Patient-Centered Oncology CareÂ® (PCOCÂ®) meeting in Baltimore on November 17, 2016, with an update on chimeric antigen receptor T-cell therapy.

February 20th 2017

Responding to Patient Needs Central to Providing Value in Cancer Care

Christina Mattina

At the 5th annual Patient-Centered Oncology CareÂ® meeting, Nell Wood Buhlman of Press Ganey explained that oncology providers must focus on patient needs and minimize suffering in order to truly provide value in cancer care.

February 20th 2017

Immunoâ€Oncology Versus Precision Medicine: Where Is Cancer Care Headed?

Surabhi Dangi-Garimella, PhD

At the 5th annual Patient-Centered Oncology CareÂ® meeting, hosted by The American Journal of Managed CareÂ®, experts discussed the contradiction presented by immuno-oncology agents in the world of precision medicine.

February 20th 2017

The Future of Oncology Care: 2017 and Beyond

Christina Mattina

Bruce A. Feinberg, DO, moderated a panel at the 5th annual Patient-Centered Oncology CareÂ® meeting that brought stakeholders together to share their cancer care predictions for the upcoming year.

February 20th 2017

Cancer Trial Participants Can Successfully Self-Report Adverse Events

Christina Mattina

Adverse events from cancer clinical trials are currently reported by trial investigators, but a recent feasibility study found that patients can successfully and accurately report their own symptoms if given the opportunity.

February 19th 2017

OlympiAD Trial Reports Success With Olaparib and Predictive Diagnostic Test

Surabhi Dangi-Garimella, PhD

The trial successfully improved progression-free survival and also tested a BRCA diagnostic test in patients with ovarian cancer.

February 19th 2017

Dr Carrie Stricker on How Carevive Integrates Patient-Reported Outcomes Into Care Planning

Carevive recognizes the importance of including patient-reported outcomes into the care planning process, so they have developed surveys that will provide patients with the resources to address those concerns, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

February 17th 2017

Pharma—PBM War on Drug Prices Picks Up Steam

Surabhi Dangi-Garimella, PhD

An e-mail, from Mark Merritt, president and CEO of the trade group Pharmaceutical Care Management Association, to the organization’s board, lays out a plan to develop an aggressive campaign to convince the new administration that the fault rests with pharmaceutical manufacturers.

February 17th 2017

This Week in Managed Care: February 17, 2017

This week, the top managed care stories included the end of 2 insurance megamergers, a proposed rule to tighten restrictions for the Affordable Care Act, and new legislation in New Jersey provides the nation's strictest mandates for treating addiction.

February 17th 2017

Pam Mangat on the Future of Surrogate Endpoints and Genetic Sequencing in Cancer Care

Surrogate endpoints could eventually add to or replace clinical endpoints in determining a cancer treatment’s effectiveness, according to Pam Mangat, MS, associate director TAPUR study at the American Society of Clinical Oncology. She also said that a deeper understanding of a patient’s genetic makeup and tumor biology in conjunction with new technologies will drive improvements in oncology care.

February 16th 2017

Advanced APMs and the Emerging Role of Immuno-Oncology Agents: Balancing Innovation and Value

Michael V. Seiden, MD, PhD Marcus Neubauer, MD Diana Verrilli

The shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?

February 16th 2017

Helping Cancer Patients and Caregivers Navigate Immunotherapy Treatment

Claire Saxton, MBA Joanne Buzaglo, PhD Sue Rochman, MA Alexandra Zaleta, PhD

Patients, caregivers, and providers need education on immunotherapy treatment, support in patient-provider communications as well as support in mitigating the financial impact of immunotherapy treatment.

February 16th 2017

Postmenopausal Weight Loss Cuts Risk of Endometrial Cancer by Half

Surabhi Dangi-Garimella, PhD

Observational findings from the Women’s Health Initiative study found that an intentional weight loss regimen by postmenopausal obese women can slash their risk of endometrial cancer by 29% to 56%.

...

79 80 81 82 83 84 85 86 87

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions